Estrogen regulation of age and PTSD-associated changes in macrophage-induced neuroinflammation during HIV infection.
HIV 感染期间巨噬细胞诱导的神经炎症中雌激素对年龄和 PTSD 相关变化的调节。
基本信息
- 批准号:10707319
- 负责人:
- 金额:$ 21.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAgeAgingAnti-Inflammatory AgentsAnti-Retroviral AgentsAntibodiesAntioxidantsAstrocytesAutomobile DrivingAutopsyAwardBindingBiologicalBiometryBiotechnologyCalciumClinical TrialsCoculture TechniquesCollecting CellComputer softwareConditioned Culture MediaCoupledCytometryDataDevelopmentDiagnosisDiseaseDisease ProgressionEstradiolEstrogen Receptor alphaEstrogen ReceptorsEstrogen Replacement TherapyEstrogensExposure toFemaleFlow CytometryFutureGTP-Binding ProteinsGenderGenerationsGoalsHIVHIV InfectionsHIV-associated neurocognitive disorderHistorically Black Colleges and UniversitiesHumanIn VitroInflammationInflammatoryInstitutionKnowledgeLeadLearningLifeLife ExpectancyMacrophageMacrophage ActivationMass Spectrum AnalysisMeasuresMediatingMembraneMenopauseMentorsMicrogliaModelingMorphologyNeurocognitiveNeurocognitive DeficitNeurologicNeuronsNeuropathogenesisNeurotoxinsNuclear ReceptorsPathogenesisPatientsPersonsPhenotypePost-Traumatic Stress DisordersPostmenopausePremenopausePrincipal InvestigatorProcessProductionPropertyProteinsQuantitative Reverse Transcriptase PCRRBM5 geneRattusReceptor ActivationRecording of previous eventsRegulationReportingResearchResearch PersonnelRoleScienceSignal PathwaySignal TransductionSystemTNF geneTechniquesTestingTrainingViralWestern BlottingWomanagedaging populationantagonistantiretroviral therapybrain tissuecareercareer developmentclinical diagnosiscollegecomorbiditydata submissionexperiencehuman pluripotent stem cellimaging softwareinduced pluripotent stem cellmalemenmonocytenervous system disorderneuroAIDSneuroinflammationneuroprotectionneurotoxicitynovelnovel therapeutic interventionpsychiatric comorbidityreceptorreceptor expressionskill acquisitionskillssuccesssynergismtargeted treatmenttherapeutic targettraining opportunitytranslational research program
项目摘要
Project Summary/Abstract
30-50% of persons living with HIV still suffer from neurological co-morbidities, including HIV-associated
Neurocognitive Disorders (HAND) and Post-traumatic stress disorder (PTSD), despite the success of combined
Antiretroviral Therapy (cART). Persistent macrophage and microglia driven neuroinflammation is seen as a
common underlying factor in HAND and PTSD disease progression. The long-term objective of this research is
to understand the underling mechanisms that influence neuroinflammatory processes in neurological disorders
to target more specific endogenous signaling mechanisms for development of novel therapeutic approaches. In
this study we will explore estrogen signaling in macrophages and microglia as a possible therapeutic target. 17β-
estradiol, the most active form of estrogen, is reduced in postmenopausal women. Studies have shown that 17β-
estradiol is neuroprotective and its reduced expression may correlate with worse HIV and PTSD disease
progression. However, how changes in estrogen concentrations and its receptors may modulate HIV-induced
neurocognitive impairment in the post-menopausal women living with PTSD is unknown. Therefore, we
hypothesize that macrophage and microglia induced neuroinflammation will be suppressed by estrogen,
in an GPER dependent manner, in the aging female compared to males and pre-menopausal females
living with Post-traumatic stress disorder and HIV. To address this hypothesis, we will utilize 2 in vitro HIV
neuroinflammatory models: 1. A co-culture system composed of rat cortical neurons and human monocytes
derived macrophages isolated from PTSD donors and 2. A co-culture system of iMicroglia and iNeurons derived
from human pluripotent stem cells from healthy donors. iMicroglia and macrophages from pre and
postmenopausal women and aged matched men will be pretreated with various concentrations of estrogen prior
to HIVADA exposure to explore the following Specific Aims: 1) Evaluate estrogen’s ability to suppress HIV-
induced neuroinflammation in PTSD-hMDM and Microglia. 2) Evaluate the role of estrogen receptors in
HIV and PTSD-induced neuroinflammation. In this proposed award, we expect hMDMs from post-menopausal
female PTSD donors and iMicroglia will have increased HIV-induced neuroinflammation, which can be
suppressed by GPER activation. The principal investigator’s career goals are to lead an independent translation
research program while increasing diversity in the sciences at a Historically Black College and University
(HBCU). To accomplish this, the PI has developed a strong training plan that will expand her expertise in the
NeuroAIDS and PTSD field, increase her skillset in the generation of iPSC, flow cytometry, mass cytometry,
biostatistical analysis and generate data for future R awards. This training will be guided by the strong mentoring
committee of investigators from Spelman College and neighboring Research 1 institutions. With success of this
project, we will elucidate the role of estrogen signaling as a potential endogenous targeted therapeutic avenue
for persons living with HAND, PTSD and other neuroinflammatory disorders.
项目概要/摘要
30-50% 的艾滋病毒感染者仍然患有神经系统并发症,包括与艾滋病毒相关的疾病
神经认知障碍(HAND)和创伤后应激障碍(PTSD),尽管联合治疗取得了成功
抗逆转录病毒疗法(cART)被视为持续性巨噬细胞和小胶质细胞驱动的神经炎症。
HAND 和 PTSD 疾病进展的共同潜在因素 这项研究的长期目标是。
了解影响神经系统疾病的神经炎症过程的基本机制
针对更具体的内源性信号传导机制来开发新的治疗方法。
在这项研究中,我们将探索巨噬细胞和小胶质细胞中的雌激素信号传导作为可能的治疗靶点。
雌二醇是雌激素最活跃的形式,在绝经后女性中,17β- 会减少。
雌二醇具有神经保护作用,其表达减少可能与 HIV 和 PTSD 疾病恶化相关
然而,雌激素进展浓度及其受体的变化如何调节 HIV 诱导的
患有 PTSD 的绝经后妇女的神经认知障碍尚不清楚。
雌激素会迅速抑制巨噬细胞和小胶质细胞诱导的神经炎症,
与男性和绝经前女性相比,老年女性以 GPER 依赖性方式
患有创伤后应激障碍和艾滋病毒的人为了解决这一假设,我们将利用 2 种体外艾滋病毒。
神经炎症模型:1.大鼠皮质神经元和人单核细胞组成的共培养系统
2. 衍生自 PTSD 供体的巨噬细胞和 iMicroglia 和 iNeurons 的共培养系统
来自健康捐赠者的人类多能干细胞和来自前和后的巨噬细胞。
绝经后妇女和年龄匹配的男性将在术前接受不同浓度的雌激素预处理
HIVADA 暴露探索以下具体目标: 1) 评估雌激素抑制 HIV 的能力
PTSD-hMDM 和小胶质细胞中诱导的神经炎症 2) 评估雌激素受体在 PTSD-hMDM 和小胶质细胞中的作用。
在这个拟议的奖项中,我们预计绝经后会出现 HIV 和 PTSD 诱发的神经炎症。
女性 PTSD 捐献者和 iMicroglia 会增加 HIV 诱发的神经炎症,这可能是
首席研究员的职业目标是领导独立翻译。
在历史悠久的黑人学院和大学开展研究计划,同时增加科学的多样性
为了实现这一目标,PI 制定了一项强有力的培训计划,以扩展她在该领域的专业知识。
NeuroAIDS 和 PTSD 领域,提高她在 iPSC 生成、流式细胞术、质谱流式细胞术、
生物统计分析并为未来的 R 奖项生成数据,该培训将得到强有力的指导。
斯佩尔曼学院和邻近的研究机构 1 的研究人员委员会取得了成功。
项目中,我们将阐明雌激素信号传导作为潜在内源性靶向治疗途径的作用
适用于患有手部疾病、创伤后应激障碍和其他神经炎症性疾病的人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kimberly S. Williams其他文献
Cell trafficking through the choroid plexus
- DOI:
10.4161/cam.21054 - 发表时间:
2012-09-01 - 期刊:
- 影响因子:3.2
- 作者:
R. Meeker;Kimberly S. Williams;D. Killebrew;L. Hudson - 通讯作者:
L. Hudson
Neuroinflammation and EIF2 Signaling Persist despite Antiretroviral Treatment in an hiPSC Tri-culture Model of HIV Infection
尽管在 HIV 感染的 hiPSC 三培养模型中进行了抗逆转录病毒治疗,但神经炎症和 EIF2 信号转导仍然存在
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:5.9
- 作者:
Sean K. Ryan;Michael V. Gonzalez;James P Garifallou;F. C. Bennett;Kimberly S. Williams;Nathaniel P. Sotuyo;E. Mironets;Kieona Cook;H. Hakonarson;S. Anderson;K. Jordan - 通讯作者:
K. Jordan
Neuroinflammation and EIF2 signaling persist in an HiPSC tri-culture model of HIV infection despite antiretroviral treatment
尽管进行了抗逆转录病毒治疗,但 HIV 感染的 HiPSC 三培养模型中神经炎症和 EIF2 信号传导仍然存在
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Sean K. Ryan;Michael V. Gonzalez;James P Garifallou;F. C. Bennett;Kimberly S. Williams;H. Hakonarson;S. Anderson;K. Jordan - 通讯作者:
K. Jordan
NEUROTROPHIN-CHEMOKINE RECEPTOR INTERACTIONS ON MACROPHAGES REGULATE HIV NEUROPATHOGENESIS
巨噬细胞上的神经营养因子-趋化因子受体相互作用调节 HIV 神经发病
- DOI:
- 发表时间:
2015-05-01 - 期刊:
- 影响因子:4
- 作者:
Kimberly S. Williams - 通讯作者:
Kimberly S. Williams
Kimberly S. Williams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kimberly S. Williams', 18)}}的其他基金
Estrogen regulation of age and PTSD-associated changes in macrophage-induced neuroinflammation during HIV infection.
HIV 感染期间巨噬细胞诱导的神经炎症中雌激素对年龄和 PTSD 相关变化的调节。
- 批准号:
10572654 - 财政年份:2022
- 资助金额:
$ 21.1万 - 项目类别:
Neurotrophin- Chemokine Receptor Interactions Regulate Macrophage Activation
神经营养蛋白-趋化因子受体相互作用调节巨噬细胞激活
- 批准号:
8659199 - 财政年份:2013
- 资助金额:
$ 21.1万 - 项目类别:
Neurotrophin- Chemokine Receptor Interactions Regulate Macrophage Activation
神经营养蛋白-趋化因子受体相互作用调节巨噬细胞激活
- 批准号:
8542294 - 财政年份:2013
- 资助金额:
$ 21.1万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:
10735662 - 财政年份:2023
- 资助金额:
$ 21.1万 - 项目类别:
Examining the Effectiveness of the Early Start Denver Model in Community Programs serving Young Autistic Children
检查早期开始丹佛模式在为自闭症儿童服务的社区项目中的有效性
- 批准号:
10725999 - 财政年份:2023
- 资助金额:
$ 21.1万 - 项目类别:
Development of M-Drive: A recyclable Mucor-optimized CAS9 gene-drive system cable of multi-target gene editing
开发M-Drive:可回收的多靶点基因编辑的毛霉优化CAS9基因驱动系统电缆
- 批准号:
10727359 - 财政年份:2023
- 资助金额:
$ 21.1万 - 项目类别:
Plasma neurofilament light chain as a potential disease monitoring biomarker in Wolfram syndrome
血浆神经丝轻链作为 Wolfram 综合征潜在疾病监测生物标志物
- 批准号:
10727328 - 财政年份:2023
- 资助金额:
$ 21.1万 - 项目类别: